As global health institutions and aid donors expanded HIV treatment throughout Africa, they rapidly ""scaled up"" programs, projects, and organizations meant to address HIV and AIDS. Yet these efforts did not simply have biological effects: in addition to extending lives and preventing further infections, treatment scale-up initiated remarkable political and social shifts. In Lesotho, which has the world's second highest HIV prevalence, HIV treatment has had unintentional but pervasive political costs, distancing citizens from the government, fostering distrust of health programs, and disrupting the social contract. Based on ethnographic observation between 2008 and 2014, this book chillingly anticipates the political violence and instability that swept through Lesotho in 2014. This book is a recipient of the Norman L. and Roselea J. Goldberg Prize from Vanderbilt University Press for the best book in the area of medicine.

As global health institutions and aid donors expanded HIV treatment throughout Africa, they rapidly ""scaled up"" programs, projects, and organizations meant to address HIV and AIDS. Yet these efforts did not simply have biological effects: in addition to extending lives and preventing further infections, treatment scale-up initiated remarkable political and social shifts. In Lesotho, which has the world's second highest HIV prevalence, HIV treatment has had unintentional but pervasive political costs, distancing citizens from the government, fostering distrust of health programs, and disrupting the social contract. Based on ethnographic observation between 2008 and 2014, this book chillingly anticipates the political violence and instability that swept through Lesotho in 2014. This book is a recipient of the Norman L. and Roselea J. Goldberg Prize from Vanderbilt University Press for the best book in the area of medicine.

There is growing evidence of the wide-ranging impacts of corporations in selected industries on global patterns of health and disease. However, limited analysis has been undertaken of the increasing corporate involvement in collective action needed to effectively address these impacts. This book brings together a wide ranging collection of case studies that provide new empirical research on how corporations impact on, influence of, and could be held more accountable to, global health governance. Written by leading and emerging scholars from a broad range of disciplinary perspectives, each case study seeks to expand the methods, conceptual approaches and sources of data used to address three key questions: *What impacts are corporations having on global health governance? *How do corporations shape and influence global health governance in ways that protect and promote their own interests? *What forms of global health governance are needed to mediate these corporate impacts in ways that protect and promote population health? Also, for a practical guide on how to conduct research on the impact of corporations on global health and global health governance, see the partner volume: http://www.rowmaninternational.com/books/researching-corporations-and-global-health-governance

The global expansion of HIV programming (HIV "scale-up") and the growth of global health in the past decade reshaped politics, power, civic relations, and citizen subjectivities in countries across the globe. This book draws on interdisciplinary research from numerous sites in the Global South to examine the political dimensions of HIV and global health programming. The chapters reflect extensive methodological diversity and geographic range, yet exhibit striking resonance with the book's core themes. Collectively, the authors paint a complex global portrait of a unique period in the social history of HIV, as the pandemic enters its fourth decade, and the global response reaches its peak. The book contemplates "scale-up" (and, subsequently, "scale-down") as an object of analysis and an historical shift in the politics of response to global crisis. Ultimately, HIV/AIDS campaigns provide a template for the broader expansion of global health projects and institutions. These transnational shifts and expansions necessitate further critical evaluations across social science and public health disciplines. By collecting diverse perspectives on the political legacies of HIV and global health, this book provides a unique history of the present, cataloguing emerging practices and policies that will have long-term social impacts. This book was originally published as a special issue of Global Public Health.

The global expansion of HIV programming (HIV "scale-up") and the growth of global health in the past decade reshaped politics, power, civic relations, and citizen subjectivities in countries across the globe. This book draws on interdisciplinary research from numerous sites in the Global South to examine the political dimensions of HIV and global health programming. The chapters reflect extensive methodological diversity and geographic range, yet exhibit striking resonance with the book's core themes. Collectively, the authors paint a complex global portrait of a unique period in the social history of HIV, as the pandemic enters its fourth decade, and the global response reaches its peak. The book contemplates "scale-up" (and, subsequently, "scale-down") as an object of analysis and an historical shift in the politics of response to global crisis. Ultimately, HIV/AIDS campaigns provide a template for the broader expansion of global health projects and institutions. These transnational shifts and expansions necessitate further critical evaluations across social science and public health disciplines. By collecting diverse perspectives on the political legacies of HIV and global health, this book provides a unique history of the present, cataloguing emerging practices and policies that will have long-term social impacts. This book was originally published as a special issue of Global Public Health.

There is growing evidence of the wide-ranging impacts of corporations in selected industries on global patterns of health and disease. However, limited analysis has been undertaken of the increasing corporate involvement in collective action needed to effectively address these impacts. This book brings together a wide ranging collection of case studies that provide new empirical research on how corporations impact on, influence of, and could be held more accountable to, global health governance. Written by leading and emerging scholars from a broad range of disciplinary perspectives, each case study seeks to expand the methods, conceptual approaches and sources of data used to address three key questions: *What impacts are corporations having on global health governance? *How do corporations shape and influence global health governance in ways that protect and promote their own interests? *What forms of global health governance are needed to mediate these corporate impacts in ways that protect and promote population health? Also, for a practical guide on how to conduct research on the impact of corporations on global health and global health governance, see the partner volume: http://www.rowmaninternational.com/books/researching-corporations-and-global-health-governance